VC-backed JenaValve beefs up Munich team with new hire
JenaValve Technology Inc, a maker of transcatheter aortic valve replacement systems, has named Pieter Van den Steen as chief commercial officer and general manager of the company's Munich office. Previously, Van den Steen worked at Boston Scientific. JenaValve's backers included Atlas Venture, Edmond de Rothschild Investment Partners, Gimv, Legend Capital, NeoMed Management, Omega Funds, RMM, Sunstone Capital, Valiance and VI Partners.
22 January 2016•3 mins read
